| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $16K | -66.7% | -98.7% |
| R&D Expense | $11.1M | +26.6% | +23.3% |
| SG&A Expense | $6.6M | +40.1% | +8.7% |
| Operating Income | -$17.7M | -31.7% | -27.7% |
| Pre-tax Income | -$17.1M | -33.4% | -33.7% |
| Income Tax | $61K | +10.9% | +7.0% |
| Net Income | -$17.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $37.8M | -6.9% | — |
| Short-term Investments | $16.9M | -45.6% | — |
| Accounts Receivable | $17K | — | — |
| Current Assets | $62.6M | -19.5% | — |
| Total Assets | $67.4M | -18.6% | — |
| Current Liabilities | $11.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$40.0M | — | — |
| Capital Expenditures | $418K | — | — |
| Investing Cash Flow | -$1.2M | — | — |
| Financing Cash Flow | $378K | — | — |
| Free Cash Flow | -$40.4M | — | — |
| -33.3% |
| -33.6% |
| EPS (Basic) | -$0.31 | -34.8% | -34.8% |
| EPS (Diluted) | -$0.31 | -34.8% | -34.8% |
| +6.4% |
| — |
| Total Liabilities | $12.0M | +5.3% | — |
| Stockholders' Equity | $55.4M | -22.4% | -45.0% |